HSV I+II DNT

33 Azn

Even very small amounts of viral particles in biological material can be detected by PCR testing. Regardless of the time of infection, PCR allows the identification of herpes viruses even during the period when antibodies have not yet formed. The most common types are Herpes Simplex Virus type 1 (HSV-1) and type 2 (HSV-2). Both are contagious and can cause small fluid-filled blisters on the mucous membranes and skin. HSV-1 commonly causes blisters around and inside the mouth, while HSV-2 usually affects the genital area.

Herpes simplex virus can spread through direct skin-to-skin contact, even when visible lesions or blisters are not present. HSV-2 is commonly classified as a sexually transmitted infection (STI). In cases of primary infection, painful blisters usually appear at the site of infection within two weeks and often resolve within four weeks. Lesions may develop on the genitals, anus, buttocks, or thighs and can sometimes spread to nearby areas. Patients may also experience flu-like symptoms, including fever, sore throat, and general weakness.

Herpes infection does not always cause visible blisters. In some cases, the symptoms may be so mild that they can be mistaken for insect bites, skin irritation, or allergies. Once the infection enters the body and spreads, the herpes virus remains dormant and may reactivate later due to stress, weakened immunity, or other illnesses that affect the immune system. In most cases, herpes simplex is not dangerous to health, but it can cause serious diseases: neonatal herpes (if the baby is infected from the mother's genitals during childbirth) and encephalitis. These can cause serious, incurable neurological diseases and even death. The following factors increase the risk of contracting herpes:

  • Diseases that weaken the immune system (such as HIV / AIDS),
  • Transplantation.

Currently, there is no cure for herpes, but there are antiviral drugs that reduce the spread, as well as shorten the duration of the acute phase of the viral infection and relieve the symptoms of the disease.

  • The material should be taken 2 weeks after antiviral therapy.
  • Detection of genital herpes virus infection in men and women and monitoring the effectiveness of treatment.
  • Herpes screening for women before pregnancy and during pregnancy (if there is a risk of infection).
  • Determination of the presence of genital herpes infection when clinically indicated.

Positive result

  • The organism is infected with the virus. The result is evaluated based on the amount of genetic material detected during the test.

Negative result

  • No infection with the genital herpes virus was detected.